The US Supreme Court will decide a case involving 2 insurance companies that claimed they were shorted $12 billion by the federal government for "risk corridor" payments related to the ACA; Missouri's last abortion clinic will stay open until at least Friday after a state circuit court judge extended a preliminary injunction he previously issued; City of Hope will invest $1 billion in a new cancer research center and hospital in Irvine, California.
Yesterday, the US Supreme Court agreed to decide whether Congress acted correctly when it failed to fully fund “risk corridors,” financial protections that were offered to health insurers that took part in marketplaces under the Affordable Care Act (ACA), according to The New York Times. In their brief, insurers said they were victims of a massive “bait and switch,” and the government paid them $12 billion less than what they were promised. Some companies that were paid less than promised have since gone bankrupt. The Supreme Court will hear consoldiated suits after a divided 3-judge appellate panel ruled against the insurance companies last year.
Missouri Circuit Court Judge Michael Stelzer ruled yesterday that the state’s only abortion clinic can continue performing abortions through Friday, The New York Times reported. Stelzer extended a preliminary injunction he previously issued to give the clinic time to take a licensing fight before an administrative panel. The clinic will be forced to shut down if its license isn’t renewed and would make Missouri the first state since 1974 to lack a facility where abortions can be performed.
City of Hope will invest $1 billion in a new hospital and research center focused on cancer care in Irvine, California, the Los Angeles Times reported. Without convenient access to care, about 20% of Orange County patients have previously been forced to travel long distances to seek care elsewhere. City of Hope expects to convert an unused building on recently purchased property into a research center by 2021, and to complete construction on the hospital by 2025.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More